A Retrospective Observational Study to Describe Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State, in Routine Clinical Practice in Spain.

Ipsen1 site in 1 country407 target enrollmentApril 2012

Overview

Phase: N/A
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: Ipsen
Enrollment: 407
Locations: 1
Primary Endpoint: Prior treatment before progression to advanced or metastatic disease.
Status: Completed
Last Updated: 7 years ago

The purpose of the protocol is to describe treatment patterns among patients with prostate cancer prior to diagnosis of castration-resistant state.

Registry

clinicaltrials.gov

Start Date

April 2012

End Date

May 2013

Last Updated

7 years ago

Study Type

Observational

Sex

Male

Sponsor

Responsible Party

Sponsor

•Age ≥ 18 years
•Patients with prostate cancer who had developed a castration resistant state in the last 24 months prior to starting the study
•Patient must give written informed consent before any study related procedure

•Patients with medical histories lacking data required to evaluate the study objectives

Prior treatment before progression to advanced or metastatic disease.

Time Frame: Baseline

Number of participants with each category of treatment.

Treatment of advanced or metastatic disease.

Time Frame: Baseline

Number of participants with each category of treatment.

Demographic data.(Baseline)
Number of CRPC patients with signs and symptoms of metastatic disease.(Baseline)
Time to castration resistant state after beginning of hormonotherapy.(Baseline)
Clinical management of Castration-Resistant Prostate Cancer (CRPC) patients in the clinical practice.(Baseline)